Irbesartan is available for oral administration in unscored tablets containing 75 mg, 150 mg, or 300 mg of Irbesartan USP
is voluntarily recalling listed lots, within expiry, of Irbesartan Tablets, USP 75 mg, 150 mg, and 300 mg dosage forms to the consumer level
Aurobindo Pharma Limited is voluntarily recalling 22 Batches of the drug substance Irbesartan due to the presence of an impurity, N-nitrosodiethylamine
5-10/4
Multi event Drug Recall Enforcement Report Class II voluntary initiated by Lupin Pharmaceuticals Inc
Sanofi Aventis has Avapro
The investigation is ongoing and the FDA continues to update the list Irbesartan Strength 75 mg Imprint H 158 Color White Shape Capsule/Oblong View details
The MHRA today has issued a recall for 25 batches of Irbesartan-containing medicinal products due to contamination with an impurity that could potentially increase the risk of Published
issues voluntary nationwide recall of Irbesartan tablets, USP 75 mg, 150 mg, and 300 mg due to the detection of trace amounts of NDEA (N-nitrosodiethylamine) impurity found in the active pharmaceutical ingredient
Drug Recall Subcategory: Drugs Hazard classification: Type I Source of recall: Health Canada Issue: Product Safety Audience: PMS-Irbesartan 75 mg Tablet; DIN, NPN, DIN-HIM DIN 02317060 Dosage form
617466, 617467, 617468, 620272, 622195, 624738 Lupin Pharmaceuticals is recalling all batches of irbesartan tablets USP 75 mg, 150 mg, and 300 mg and irbesartan and hydrochlorothiazide (HCTZ) tablets USP 150 mg/12
Ingredients
FT00969, FT01225, FT01226, FT01999, FT04262
Nonmedicinal ingredients: cellulose microcrystalline, croscarmellose sodium, hypromellose, lactose monohydrate, hydroxypropylcellulose, magnesium stearate, polyethylene glycol, silica colloidal anhydrous, talc, and titanium
yellow eyes or skin
Zantac Maximum Strength Non-Prescription (ranitidine) 02277301: 150 mg: All lots: Initial recall notice: Batch Number 0R855 Exp date: Sep 2023 Revised recall notice: Batch Number 0R855 Exp date: Apr 2023 Aprovel 300mg Film-Coated Tablets, EU/1/97/046/027, (PLGB 04425/0789 Irbesartan is a generic drug available as an oral tablet in strengths of 75 mg, 150 mg, and 300 mg